Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Hal Barnett who wrote (384)	5/21/1999 12:56:00 AM
From: BradleyMarshall	Respond to of 3158

I don't know who PCOP is, but I've definitely thought of INCY, ABSC, and maybe ArQule (ARQL), to give them the full spectrum (genomics, screeing and combichem). If you want an analagous situation, look at Axys pharm. A genomics and a combi chem company combined to create "the first genes to drugs company." Their stock has exploded from eight down to four. (However, I think it's a great idea, nonetheless)